Surgical excision of heterotopic bone after hip surgery followed by oral indomethacin application: Is there a clinical benefit for the patient?

Archives of Orthopaedic and Trauma Surgery

Volumn 119, Issue 3-4, 1999, Pages 151-155

  Wick, M ^a   Muller E J ^a   Hahn, M P ^a   Muhr, G ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; SUCRALFATE;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; ECTOPIC TISSUE; FEMALE; GASTROINTESTINAL SYMPTOM; HIP SURGERY; HUMAN; JOINT MOBILITY; MALE; ORAL DRUG ADMINISTRATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHROPLASTY, REPLACEMENT, HIP; FEMALE; HIP JOINT; HUMANS; INDOMETHACIN; MALE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; POSTOPERATIVE PERIOD; RANGE OF MOTION, ARTICULAR; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0345280746     PISSN: 09368051     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004020050379     Document Type: Article

References (47)

1. Ahrengart L, Lindgren U (1993) Heterotopic bone after hip arthroplasty. Defining the patient at risk. Clin Orthop 293: 153-159
2. Amstutz HC, Fowble VA, Schmalzried TP, Dorey FJ (1997) Short course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty. J Arthroplasty 12: 126-132
3. Azcarate JR, Pablo J de, Cornejo F, Canadell J (1986) Postoperative dislocation: a risk factor for periprosthetic ectopic ossification after total hip replacement. Acta Orthop Belg 53: 145-150
4. Brooker AF, Bowerman JW, Robinson RA, Riley LH (1973) Ectopic ossification following total hip replacement. J Bone Joint Surg [Am] 55: 1629-1632
5. Caron JC (1976) Para articular ossification in total hip replacement. In: Total hip prostheses. Hans Huber, Bern, pp 171-185
6. Cella JP, Salvati EA, Sculco TP (1988) Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects. J Arthroplasty 3:229-234
7. Charnley J (1972) The long-term results of low-friction arthroplasty of the hip performed as a primary intervention. J Bone Joint Surg [Br] 54:61-76
8. Coventry MB, Scanlon PW (1981) The use of radiation to discourage ectopic bone. A nine-year study in surgery about the hip. J Bone Joint Surg [Am] 63:201-208
9. De Flitch CJ, Stryker JA (1993) Postoperative hip irradiation in prevention of heterotopic ossification: causes of treatment failure. Radiology 188:265-270
10. Duck HJ, Mylod AG (1992) Heterotopic bone in hip arthroplasties. Cemented versus noncemented. Clin Orthop 282: 145-153
11. Eulert J, Barthel T (1997) Heterotope Ossifikationen. Orthopäde 26:399-406
12. Fingerroth RJ, Ahmed AQ (1995) Single dose 6 Gy prophylaxis for heterotopic ossification after total hip arthroplasty. Clin Orthop 317: 131-140
13. Francis MD, Russel RCG, Fleisch H (1969) Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science 165: 1264-1266
14. Hamblen DL, Harris WH, Rottiger J (1961) Myositis ossificans as a complication of arthroplasty. In: Proceedings of the British Orthopaedic Association. J Bone Joint Surg [Br] 53:764-769
15. Healey WL, Lo TCM, DeSimone AA, Rask B, Pfeifer BA (1995) Single-dose irradiation for the prevention of heterotopic ossification after total hip arthroplasty. J Bone Joint Surg [Am] 4:590-595
16. Jowsey J, Coventry MB, Robins PR (1977) Heterotopic ossification: theoretical consideration, possible etiologic factors, and a clinical review of total hip arthroplasty patients exhibiting this phenomenon. In: The hip: proceedings of the Tenth Open Scientific Meeting of the Hip Society. Mosby, St Louis, pp 210-221
17. Kjaersgaard AP, Ritter MA (1992) Short-term treatment with nonsteroidal antiinflammatory medications to prevent heterotopic bone formation after total hip arthroplasty. Clinic Orthop 279: 157-162
18. Kjaersgaard AP, Nafei A, Teichert G, Kristensen O, Schmidt SA, Keller J, Lucht U (1993) Indomethacin for prevention of heterotopic ossification: a randomized controlled study in 41 hip arthroplasties. Acta Orthop Scand 64:639-642
19. Knahr K, Salzer M, Eyb R (1988) Heterotopic ossification with total hip endoprosthesis in various models of thrombosis prophylaxis. J. Arthroplasty 3: 1-8
20. Knelles D, Barthel T, Karrer A, Kraus U, Eulert J, Kölbl O (1997) Prevention of heterotopic ossification after total hip replacement. J Bone Joint Surg [Br] 79:596-602
21. Lewallen DG (1995) Heterotopic ossification following total hip arthroplasty. Instr Course Led 44:287-292
22. Maloney WJ, Krushell RJ, Jasty M, Harris WH (1991) Incidence of heterotopic ossification after total hip replacement: effect of the type of fixation of the femoral component. J Bone Joint Surg [Am] 2: 191-193
23. McMahon JS, Waddell JP, Morton J (1991) Effect of short-course indomethacin on heterotopic bone formation after uncemented total hip arthroplasty. J Arthroplasty 6:259-264
24. Metzenroth H, Publig W, Knahr K, Zandl C, Kuchner G, Carda C (1991) Ossifikationsprophylaxe nach Hüfttotalendoprothesen mit Indomethacin und ihr Einfluss auf die Magenschleimhaut. Z Orthop Ihre Grenzgeb 129: 178-182
25. Moore TJ (1993) Functional outcome following surgical excision of heterotopic ossification in patients with traumatic brain injury. J Orthop Trauma 7: 11-14
26. Nollen JG, Douveren FQ van (1993) Ectopic ossification in hip arthroplasty. A retrospective study of predisposing factors in 637 cases. Acta Orthop Scand 64: 185-187
27. Parkinson JR, Evarts C, Hubbard LF (1982) Radiation therapy in the prevention of heterotopic ossification after total hip arthroplasty. In: The hip: Proceedings of the Tenth Open Scientific Meeting of the Hip Society. Mosby, St Louis, pp 211-227
28. Pellegrini VD, Gregoritch SJ (1996) Preoperative irradiation for prevention of heterotopic ossification following total hip arthroplasty. J Bone Joint Surg [Am] 78:870-881
29. Plasmans CMC, Kuypers WM, Sloof TJJH (1978) The effect of ethane-1-hydroxyl-1,1 diphosphonic acid (EHDP) on matrix-induced ectopic bone formation. Clin Orthop 132:233-243
30. Riegler HF, Harris CM (1976) Heterotopic bone formation after total hip arthroplasty. Clin Orthop 117:209-216
31. Ritter MA, Vaughan RB (1977) Ectopic ossification after total hip arthroplasty. Predisposing factors, frequency, and effect on results. J Bone Joint Surg [Am] 59:345-351
32. Rubenstein JH, Salenius SA, Blitzer PH, Katin MJ, Dosoretz DE (1992) Prevention of heterotopic bone formation with low dose radiation therapy. J Fla Med Assoc 79:828-832
33. Schmidt SA, Kjaersgaard AP, Pedersen NW, Kristensen SS, Pedersen P, Nielsen JB (1988) The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized double-blind clinical trial. J Bone Joint Surg [Am] 70:834-838
34. Seegenschmiedt MH, Goldmann AR, Martus P, Wölfel R, Hohmann D, Sauer R (1993) Prophylactic radiation therapy for prevention of heterotopic ossification after hip arthroplasty: results in 141 high-risk hips. Radiology 188:257-264
35. Seegenschmiedt MH, Goldmann AR, Wölfel R, Hohmann D, Beck H, Sauer R (1993) Prevention of heterotopic ossification (HO) after total hip replacement: randomized high versus low dose radiotherapy. Radiother Oncol 26:271-274
36. Sell S, Jany R, Kremling E, Esenwein S, Herr G, Gaissmaier C, Bamberg M, Kusswetter W (1995) Suppression of heterotopic ossification: single-dose versus fractionated iradiation. An animal study. Z Orthop Ihre Grenzgeb 133:514-519
37. Sell S, Jany R, Kremling E, Esenwein S, Gaissmaier C, Kusswetter W (1996) Prevention of heterotopic ossification following cementless hip replacement using 5 × 2 Gy fractionated irradiation. A prospective study. Z Orthop Ihre Grenzgeb 134: 375-380
38. Singer FR, Minoofar PN (1995) Biphosphonates in the treatment of disorders of mineral metabolism. Adv Endocrinol Metab 6:259-264
39. Sodemann B, Persson PE, Nilsson OS (1988) Prevention of heterotopic ossification by nonsteroid antiinflammatory drugs after total hip arthroplasty. Clin Orthop 237: 158-163
40. Spry NA, Dally MJ, Benjamin B, Chapman P, Morum P, Christie DR (1995) Heterotopic bone formation affecting the hip joint is preventable in high risk patients by post-operative radiation. Australas Radiol 39: 379-383
41. Thomas BJ (1992) Heterotopic bone formation after total hip arthroplasty. Orthop Clin North Am 23: 347-358
42. Tozun R, Pinar H, Yessiler E, Hamzaoglu A (1992) Indomethacin for prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty 7:57-61
43. Wahlstrom O, Rislo O, Djerf K, Hammerby S (1991) Heterotopic bone formation prevented by diclofenac. Prospective study of 100 hip arthroplasties. Acta Orthop Scand 62:419-421
44. Warren SB, Brooker AF (1992) Excision of heterotopic bone followed by irradiation after total hip arthroplasty. J Bone Joint Surg [Am] 74:201-210
45. Weissinger M, Keppel A, Helmreich C (1994) Retrospektive Studie über heterotope Ossifikationen mit und ohne Indomethacinprophylaxe. Acta Chir Orthop Traumatol Cech 61: 87-91
46. Wise MW, Robertson ID, Lachiewicz PF, Trall DE, Metcalf M (1990) The effect of radiation therapy on the fixation strength of an experimental porous-coated implant in dogs. Clin Orthop 261:276-280
47. Wurnig C, Eyb R, Auersperg V (1992) Indomethacin for prevention of ectopic ossification in cementless hip arthroplasties. A prospective 1-year study of 100 cases. Acta Orthop Scand 63:628-630